Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
Job F.M. van Boven, Boudewijn J.H. Dierick, Omar S. Usmani
Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Job F.M. van Boven, Boudewijn J.H. Dierick, Omar S. Usmani. When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?. Eur Respir J, 58 (3) 2100304; 10.1183/13993003.00304-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Sleep disturbance and growth stagnation in a 6-year-old child
Managing COVID-19 illness: chest radiographs support defining both prognosis and follow up.
A 51-year-old man with 10-day history of cough, fever, odynodysphagie, dyspnea and fatigue
Related content which might interest you:
Understanding patient’ adherence to inhaled medication: the social representations of COPD
Source: International Congress 2017 – COPD management
What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß
-agonist use in asthma
Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019
Do general practitioners use effective communication for discussing patients‘ adherence with asthma medications?
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Evaluating the effects of asthma therapy on childhood growth: principles of study design
Source: Eur Respir J 2002; 19: 1167-1178
Is there evidence showing that real-life aspects (comorbid conditions, inhaler technique, and lifetstyle factors) influence asthma management?
Source: International Congress 2014 – The evolving role of real-life research in respiratory medicine
Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Adherence to asthma treatment: Can it be improved in general practice?
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Physician‘s perception of pediatric asthma control is influenced by the use of medication
Source: Eur Respir J 2003; 22: Suppl. 45, 365s
Does combination therapy lead to better adherence in asthma?
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project)
Source: Eur Respir J 2002; 20: Suppl. 38, 329s
Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?
Source: Eur Respir J 2002; 19: 1179-1193
Daily pattern of ß2-agonists: understanding real-life use of rescue medication
Source: International Congress 2017 – Asthma management
The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs
Source: Eur Respir J 2012; 40: 1149-1155
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Modelling and simulation in successful drug development programmes: Characterisation of exacerbation reduction with roflumilast to corroborate the importance of defining patient subsets in COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD